Trial watch: intratumoral immunotherapy
While chemotherapy and radiotherapy remain the first-line approaches for the management of most unresectable tumors, immunotherapy has emerged in the past two decades as a game-changing treatment, notably with the clinical success of immune checkpoint inhibitors. Immunotherapies aim at (re)activatin...
Guardado en:
Autores principales: | Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, Guido Kroemer, Jonathan G. Pol |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Taylor & Francis Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/860d117f4d7c441c9071fddcbf85143f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
ANTICANCER DNA VACCINATION: PRINCIPLE AND PERSPECTIVES OF THE METHOD
por: M. V. Stegantseva, et al.
Publicado: (2017) -
Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Jagmohan Singh, et al.
Publicado: (2021) -
Intercepting Premalignant, Preinvasive Breast Lesions Through Vaccination
por: Nadia Nocera Zachariah, et al.
Publicado: (2021) -
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
por: Gi Ru Shin, et al.
Publicado: (2021) -
Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy
por: Adityanarayan Mohapatra, et al.
Publicado: (2021)